Indeed, PlGF silencing or inhibition of NF-κB restored melanoma cell sensitivity to the chemotherapeutic agent [163] Finally, VEGF-B transcript levels in the tumor measured in a large cohort of melanoma patients inversely correlated with survival [69]. This evidence concerns the gene NFKB1 and melanoma.